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Abstract Superparamagnetic iron oxide nanoparticles of
size *5 nm surface functionalized with ascorbic acid
(vitamin C) form a stable dispersion in water with a
hydrodynamic size of *30 nm. The anti-oxidant property
of ascorbic acid is retained after capping, as evidenced
from the capability of converting methylene blue to its
reduced leuco form. NMR relaxivity studies show that the
ascorbic-acid-coated superparamagnetic iron oxide aque-
ous nanofluid is suitable as a contrast enhancement agent
for MRI applications, coupled with the excellent biocom-
patibility and medicinal values of ascorbic acid.
Keywords Ascorbic acid  Iron oxide nanoparticles 
Magnetic fluids  Water dispersion  Superparamagnetic 
Relaxivity  MRI applications
Introduction
Superparamagnetic iron oxide nanoparticles (SPIONs) are
known for their very good response to external magnetic
fields which make them unique in magnetic hyperthermia,
targeted drug delivery, biosensing and magnetic resonance
imaging (MRI) applications (Laurent et al. 2008; Gupta
and Gupta 2005; Hergt et al. 2006; De et al. 2008;
Colombo et al. 2012; Xu and Sun 2013). Intensive research
works are in progress on the application of these
nanoparticles as multifunctional probes rather than their
use in single in vivo applications (Liong et al. 2008). To be
used as an efficient MRI probe requires magnetic nano-
particles with properties like superparamagnetism, high
magnetization, suitable size, apt surface chemistry and
above all good water dispersibility and biocompatibility.
Hence, water based, biocompatible, and suitably func-
tionalized magnetic nanofluids are highly desirable for
various biomedical applications.
Even though there are many reports in the literature on the
synthesis of superparamagnetic iron oxide nanoparticles,
their application is still limited due to agglomeration and the
difficulty in dispersing the particles in aqueous media, which
limit their use for in vivo applications. The superior magnetic
properties of the iron oxide nanoparticles make them highly
useful in theranostic applications. But to be used widely, the
physicochemical properties of the nanoparticles need to be
optimized. There are various reports on the synthesis of
magnetite nanoparticles with polymer surface coatings like
dextran, lipids, polyethylene glycol, polyvinyl alcohol, etc.,
giving significantly stable aqueous dispersions (Liong et al.
2008; Xu et al. 2005; Larsen et al. 2012). In spite of the
biocompatibility of these polymers, they are not preferred for
in vivo applications as they detach from the surface of the
nanoparticles, resulting in unfavourable aggregation. Also,
the large non-magnetic polymer shell will reduce the effect
of the superparamagnetic core properties limiting the
applications in various fields.
Ascorbic acid (vitamin C) is water soluble and is very
well known for its anti-oxidant property (Pardoe et al.
2001), and therefore, it is of much interest in the present
context to prepare water-soluble stable magnetic nanofluids
using ascorbic acid. As an anti-oxidant, ascorbic acid
scavenges free radicals and reactive oxygen species
(Songping and Shuyuan 2005; Davies et al. 1991). It has
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been proved to be toxic to cancer cells and is also a well-
known reducing agent both in vitro and in vivo. Ascorbic
acid has two ionizable hydroxyl groups with pKa of 4.2 and
11.6; hence it exists as ascorbate (AscH-) at physiological
pH (Deutsch 1998). Ascorbate has many biological func-
tions and is an excellent one-electron reducing agent which
reduces ferric (Fe3?) ions to ferrous (Fe2?), while being
oxidized to ascorbate radical (Du et al. 2012). Also,
ascorbic acid has a striking effect on the absorption of non-
heme iron thereby increasing the bioavailability of iron and
also it reduces and binds dietary non-heme iron (Frei and
Lawson 2008).
Successful application of magnetic resonance imaging
in clinical diagnosis requires the support of contrast
enhancement agents. Gadolinium chelate complexes are
mainly used as contrast enhancement agents in MRI which
efficiently alters the T1 relaxivity (Caravan 2006). SPIONs
are capable of replacing the gadolinium complexes due to
their biocompatibility and efficiency to alter the T2 relax-
ivity (Hoffman et al. 1991). The nanoparticles of maghe-
mite (c-Fe2O3) and magnetite (Fe3O4) can produce local
magnetic field inhomogeneities, thereby reducing the re-
laxivity of neighbouring water protons. At present there are
formulations of SPIONs available which are efficiently
used for clinical diagnosis, such as ferumoxide (dextran-
coated particles) and ferucarbotran (carboxydextran-coated
nanoparticles), with a hydrodynamic size of 120–180 and
60 nm, respectively (Qiao et al. 2009). Ultra-small super-
paramagnetic iron oxide nanoparticles (USPIONs) also act
as T1 contrast agents. Park et al. (2008) reported the syn-
thesis of polyethylene-glycol-capped iron oxide nanopar-
ticles which act both as T1 and T2 contrast agents. The
corresponding relaxivities r1 and r2 have been reported as
4.46 and 15.01 mM-1 s-1 in a magnetic field of 1.5 T.
Blood residence time of nanoparticles is known to
increase with decreasing particle size (Arruebo et al. 2007)
and larger particles are rapidly absorbed by the reticulo-
endothelial system and accumulated in the liver or spleen
preventing their availability in the blood. Hence, ultra-
small particles of iron oxide (USPIO) of hydrodynamic size
smaller than 40 nm are more advantageous for MRI
applications due to long blood circulation time (Qiao et al.
2009). Here we report the synthesis of superparamagnetic
iron oxide nanoparticles capped with ascorbic acid (vita-
min C) of much smaller size and better biocompatibility to
avoid the drawbacks caused by larger molecules. Apart
from being successful as a capping agent, the coated
ascorbic acid can efficiently act as an anti-oxidant too,
which is proved by methylene blue reduction studies. The
water dispersibility, smaller hydrodynamic size (30 nm)
and the superparamagnetic properties of the synthesized
nanoparticles make it a good candidate to be used as MRI
contrast agent. Hence, relaxivity measurements have been
carried out using NMR and found to be comparable with
values reported in the literature for other iron oxide based
contrast enhancement agents.
Experimental details
Iron oxide nanoparticles were synthesized by the reverse
co-precipitation method, wherein iron(II) chloride and
iron(III) chloride were used as the iron precursor (Sreeja
and Joy 2011; Jayaprabha and Joy 2014) and ammonium
hydroxide was used as the base. A mixed solution of 1 mM
of FeCl24H2O and 2 mM of FeCl36H2O (1:2 molar ratio
of Fe2? to Fe3?) was added to 100 ml 10 N deaerated
ammonium hydroxide solution (15 min deaeration of
NH4OH before adding the mixed iron chloride solution).
The mixture was stirred under argon atmosphere for
30 min to obtain magnetite nanoparticles. Magnetite
nanoparticles were capped with ascorbic acid by adjusting
the pH and temperature. The pH of the dispersion was
maintained at 12.5 by adding 10 N ammonia solution and
to this 0.5 g of ascorbic acid was added. Ascorbic acid
added magnetite dispersion was stirred for 1 h at 80 C to
obtain a stable, ascorbic-acid-coated magnetite nanoparti-
cle dispersion. The dispersion was dialysed against water
for three days to remove excess ascorbic acid and base. The
product was then dried in a vacuum oven and used for
further analysis. Uncoated magnetite nanoparticles were
also synthesized for comparison. The vitamin C capped
iron oxide nanoparticles are labeled as CIO and the
uncoated nanoparticles are labeled as UIO.
The anti-oxidant property of vitamin C coated on iron
oxide nanoparticles was checked by using methylene blue
(MB) as oxidizing agent (Mills et al. 2009). The reduction
behavior was studied using the magic blue bottle reaction
where ascorbic acid reduces the dye to its leuco form as
shown by the reaction given in Scheme 1 (Kundu et al.
2003). 1 g of the as-synthesized coated sample was mixed
with 10 ml of 1 mM methylene blue solution and was shaken
vigorously until the MB becomes colorless. The magnetite
nanoparticles were separated using an external magnetic
field, and the resultant solution was analyzed using UV–Vis
spectroscopy to study the conversion of MB to its leuco form.
PANalytical X’PERT PRO model X-ray diffractometer
was used to check the phase purity of the nanoparticles. An
EG&G PAR 4500 vibrating sample magnetometer was
used for the magnetic measurements. Room temperature
magnetic response of the sample was analyzed up to a field
of 1.5 T. Temperature-dependent studies were done in the
temperature range 10–300 K in a magnetic field of 50 Oe.
A FEI, TECNAI G2 TF30 transmission electron micro-
scope (TEM) was used for recording the morphology of the
nanoparticles. The sample was prepared by placing a drop
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of dilute dispersion in water on carbon-coated 200 mesh
copper grid and imaged at an accelerating voltage of
200 kV. Infrared spectra were recorded on a PerkinElmer
Spectrum-One FTIR spectrometer in the frequency range
400–4,000 cm-1. Spectroscopic grade potassium bromide
was used as background for IR analysis. Thermogravi-
metric analysis was performed on a PerkinElmer TGA7
analyzer. UV–Vis spectra were recorded on a Jasco UV–
visible spectrophotometer (V570 UV–VIS–NIR). Relaxa-
tion studies were carried out on an AV400 NMR spec-
trometer equipped with a 9.4 T magnet. Particle size of the
sample was measured by dynamic light scattering (DLS)
method using a Brookhaven instrument model 90 plus
particle size analyzer.
Results and discussion
Powder X-ray diffraction studies on the uncoated sample
indicated the formation of phase pure magnetite
nanoparticles. The average crystallite size was calculated
using the Scherrer formula and the value is obtained as
6 nm. The TEM image of the coated nanoparticles revealed
that they are of spherical shape with an average particle
size of 5 nm as shown in Fig. 1a. The average hydrody-
namic size of the coated nanoparticles is obtained from
DLS studies as 30 nm, as shown in Fig. 1b.
The effectiveness of the capping of ascorbic acid on the
surface of the iron oxide nanoparticles is confirmed by
comparing the IR spectra of ascorbic acid and the coated
Fe3O4 nanoparticles (Fig. 2). In the IR spectra of ascorbic
acid, the peaks in the range 3,215–3,520 cm-1 correspond
to the different hydroxyl groups (Panicker et al. 2006). The
characteristic absorption peak at 1,750 cm-1 in the spectra
of ascorbic acid is due to stretching vibrations of the C=O
of the five-membered lactone ring and this band is disap-
peared after coating on the nanoparticles. The C=C
stretching band shows a shift from 1,665 to 1,635 cm-1
after coating on the nanoparticles (Xiao et al. 2011). The
absence of the C=O band and the shift of the C=C band by
Scheme 1 Reaction showing
the reduction of MB by AA
Fig. 1 a TEM image and
b DLS particle size distribution
of ascorbic-acid-coated iron
oxide (CIO)
Appl Nanosci (2015) 5:435–441 437
123
*30 cm-1 after coating indicate that the C=O group of the
lactone ring essentially binds on the surface of the nano-
particles. Considerable difference in the positions of dif-
ferent bands of the coated and free ascorbic acid gives a
direct evidence for the covalent bonding of the biomolecule
on the surface of the iron oxide nanoparticles.
Figure 3 shows the thermogravimetric analysis (TGA)
curves of the ascorbic acid as well as that of the uncoated
and coated samples. The uncoated sample shows a weight
loss below 100 C due to the adsorbed moisture and/or free
hydroxyl groups. Apart from this weight loss, the coated
sample shows a weight loss of *30 % corresponding to
loss of ascorbic acid which is coated on the nanoparticles.
Further characterization was carried out by comparing
the magnetic properties of the uncoated and coated sam-
ples. Magnetization measured at room temperature as a
function of magnetic field did not show any hysteresis for
both samples, indicating the superparamagnetic nature of
the particles. It is known that inter-particle magnetic
interactions (both dipolar and exchange) will be suppressed
and negligible if the nanoparticles are effectively coated
and well separated from each other (Sreeja and Joy 2011).
The role of inter-particle magnetic interactions in the
uncoated sample and suppression of these interactions after
coating can be confirmed from field cooled (FC) and zero
field cooled (ZFC) magnetization measurements. The ZFC
and FC magnetization curves measured in a field of 50 Oe
are shown in Fig. 4. A maximum in the ZFC magnetization
curve is obtained at 100 K for the uncoated sample, cor-
responding to the superparamagnetic blocking temperature.
This temperature is reduced to 70 K after coating, indi-
cating reduction in the magnetic anisotropy contribution
from inter-particle interactions (Sreeja and Joy 2011; Jay-
aprabha and Joy 2014). The blocking temperature is related
to the size of the particle and anisotropy through the rela-
tion KV = 25kTB where TB is the blocking temperature,
V is the volume of the particle and K is the anisotropy
constant. Assuming no change in the size of the particles
after coating, TB is expected to decrease after coating due
to the reduced value of K because of the absence of
anisotropy contribution from inter-particle interactions.
Similarly, the difference in the shape of the FC magneti-
zation curves; remaining almost constant or decreasing
below TB for the uncoated particles and increasing with
decreasing temperature for the coated particles is again an
indication for the suppressed inter-particle interactions and
the effectiveness of coating.
Ascorbic acid is a well-known anti-oxidant and it is
essential that the reducing property of ascorbic acid is
retained after coating. The reduction of methylene blue by
ascorbic acid and forming its leuco form is a well-studied
reaction to measure the anti-oxidant property of ascorbic
acid. Under neutral conditions, ascorbic acid reversibly
reduces methylene blue (Mowry and Orgen 1999). The
redox indicator property of the highly coloured oxidized
Fig. 2 FTIR spectra of ascorbic acid (AA) and the coated (CIO)
nanoparticles
Fig. 3 TGA curves of ascorbic acid (AA), coated (CIO) and uncoated
(UIO) nanoparticles
Fig. 4 ZFC and FC magnetization curves for the uncoated (UIO) and
ascorbic-acid-coated (CIO) iron oxide nanoparticles
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form of methylene blue (MB?) and its stable colorless
reduced leuco form (LMB) is used in the present study to
verify whether the coated ascorbic acid is as effective as
free ascorbic acid. The redox reaction was studied using
UV–visible spectrophotometer. The UV–visible spectra of
CIO, MB before and after treatment as well as that of the
coated particles are shown in Fig. 5. A strong absorption
peak of the ascorbic acid at 237 nm indicates the p–p*
excitation of C=C double bond. MB shows peaks at 294
and 656 nm whereas LMB gives a shoulder at 256 nm. The
iron oxide nanoparticles treated MB solution shows a peak
in the lower wavelength region, with the disappearance of
peaks corresponding to MB solution. This clearly indicates
that ascorbic acid molecules capped on the surface of the
nanoparticles retain their anti-oxidant property which is
efficient to convert the dye to its bleached form, leucom-
ethylene blue. This also strongly reveals that ascorbic acid
is not leached away from the surface of the magnetite
nanoparticles when dispersed in water and is as effective as
free ascorbic acid. This observation was supported by FTIR
studies. FTIR spectra of ascorbic acid coated magnetite
nanoparticles before and after reduction using methylene
blue showed that there are no changes in the spectral
characteristics of ascorbic acid coated on the nanoparticles,
except for the minor changes in the intensities of the C–O–
H bending vibrations at 1,020, 1,120 and 1,385 cm-1 as
shown in Fig. 6.
The use of water-based nanofluids of superparamagnetic
iron oxide nanoparticles (SPIONs) coated with biocom-
patible molecules in vivo is of much interest for biomedical
applications. The use of SPIONs in MRI as contrast agents
is a well-studied area, where the nanoparticles act as neg-
ative contrast agents. The efficacy of the ascorbic-acid-
coated SPIONs is studied from T1 and T2 relaxation mea-
surements using NMR at a field of 9.4 T. The ability of
magnetite nanoparticles to act as efficient contrast agents in
MRI depends on the magnetic moment of the particles,
Fig. 5 UV–visible spectra of methylene blue (MB) and its bleached
form, leucomethylene blue (LMB) after treatment with ascorbic acid
(AA) coated iron oxide (CIO) nanoparticles
Fig. 6 FTIR spectra of CIO before (blue) and after (red) the
reduction reaction
Fig. 7 Variation of a T1 and b T2 of ascorbic-acid-coated nanopar-
ticles as a function of concentration
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which decides the proton NMR spin lattice and spin–spin
relaxation rates of water molecules (Qiao et al. 2009).
Spin–lattice relaxation, R1 and spin–spin relaxation R2 are
obtained from the reciprocals of T1 and T2, as shown in
Fig. 7. The relaxivities r1 and r2 are generally used to
quantify the enhancement efficiency and is defined as the
relaxation rate enhancement of the suspension per milli-
molar concentration of iron present. The ascorbic acid
coated iron oxide nanoparticles in the present study gives
an r1 value of 0.95 and r2 value of 22 mM
-1 s-1, the r2/r1
ratio being 23. The relaxivities were calculated by con-
sidering the number of magnetic Fe ions present per par-
ticle (Na et al. 2009). The r1 and r2 values very much
depend upon the size of the nanoparticles core, the extent
of aggregation, the dopants, surface modification, etc. (Lee
and Hyeon 2012). Clinically approved MRI contrast agents
like Ferumoxtran-10 (AMI-227) have r1 and r2 values 10
and 60 mM-1 s-1 at a field of 1.5 T (Wang 2011). The
comparatively lower values obtained in the present work
may be due to the higher magnetic field (9.5 T) used for the
relaxivity studies using NMR. It has been reported that the
relaxivity greatly depends on the strength of the magnetic
field used (Gossuin et al. 2010). The r2/r1 value obtained
for the ascorbic acid coated iron oxide nanoparticles of size
5 nm is in agreement with that reported by Bulte et al.
(1994), for protein encapsulated magnetic core of size
7 nm.
Thus, the present study shows that ascorbic acid coated
on superparamagnetic iron oxide nanoparticles is as effi-
cient as an anti-oxidant similar to free ascorbic acid and
that the water based nanofluid is efficient for contrast
enhancement in MRI applications.
Conclusions
Ascorbic acid coated on superparamagnetic iron oxide
nanoparticles of uniform size were successfully synthe-
sized by a simple co-precipitation method. IR and magnetic
measurements showed that the ascorbic acid is effectively
coated on the nanoparticles. The coated ascorbic acid is as
efficient as an anti-oxidizing agent as the free molecule as
evidenced from the reduction of methylene blue to its leuco
form. The relaxivity studies using NMR give values com-
parable to that of well-established clinical MRI contrast
agents, like ferumoxtran. Hence, the ascorbic-acid-coated
superparamagnetic iron oxide nanoparticles can be con-
sidered as a potential candidate as contrast agent in MRI,
along with its anti-oxidant and medicinal properties.
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